Published in J Exp Med on July 01, 1983
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74
Cell-mediated immune responses in tuberculosis. Annu Rev Immunol (2009) 5.90
Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1995) 4.76
Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun (1994) 4.07
Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun (1992) 3.85
Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun (1988) 3.79
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med (2011) 3.60
Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun (1986) 2.83
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun (1989) 2.51
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome. Clin Microbiol Rev (1989) 2.20
Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun (1998) 1.85
Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun (2001) 1.77
Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit Rev Immunol (2006) 1.73
Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol (1992) 1.73
Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J Immunol (2008) 1.73
The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun (2003) 1.72
Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun (1986) 1.68
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis. Infect Immun (1987) 1.63
Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes. Infect Immun (1990) 1.38
Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes. J Exp Med (1986) 1.36
Memory T cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice. Infect Immun (1991) 1.34
Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro. Infect Immun (1984) 1.31
Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol (2010) 1.26
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun (2005) 1.26
Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect Immun (2002) 1.22
Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle. Immunology (1996) 1.22
Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65. Infect Immun (1996) 1.20
Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2010) 1.17
The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol (2013) 1.15
Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun (1999) 1.15
Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol (2010) 1.13
Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect Immun (1999) 1.12
The immune response to the cell wall of Mycobacterium bovis BCG. Clin Exp Immunol (1988) 1.11
Development of new vaccines and drugs for TB: limitations and potential strategic errors. Future Microbiol (2011) 1.10
Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol (2002) 1.09
Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Am J Respir Cell Mol Biol (2008) 1.08
Dendritic cells efficiently immunoselect mycobacterial-reactive T cells in human blood, including clonable antigen-reactive precursors. Immunology (1992) 1.08
Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling. Infect Immun (2009) 1.06
T-cell immune responses in Mycobacterium avium-infected mice. Infect Immun (1992) 1.01
In vitro responsiveness of gammadelta T cells from Mycobacterium bovis-infected cattle to mycobacterial antigens: predominant involvement of WC1(+) cells. Infect Immun (2001) 0.99
Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun (2003) 0.95
Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine (2010) 0.94
Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ alphabeta and gammadelta T cells: role of particulate antigen. Infect Immun (1998) 0.93
CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol (2004) 0.93
Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice. Clin Exp Immunol (1990) 0.93
Antigens for CD4 and CD8 T cells in tuberculosis. Cold Spring Harb Perspect Med (2014) 0.93
Immunosuppressive effect of cyclosporin A on Mycobacterium bovis BCG infections in mice. Infect Immun (1987) 0.91
Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection. Eur J Immunol (2014) 0.90
Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis. Clin Exp Immunol (2007) 0.90
Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo. Infect Immun (2003) 0.90
Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed. Immunology (1989) 0.90
The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence (2012) 0.90
Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis. Clin Exp Immunol (2005) 0.81
Passive transfer of tuberculin sensitivity from anergic mice. Infect Immun (1984) 0.81
Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLoS One (2011) 0.81
Human body temperature and new approaches to constructing temperature-sensitive bacterial vaccines. Cell Mol Life Sci (2011) 0.78
Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice. Clin Exp Immunol (1993) 0.78
Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection. PLoS Pathog (2016) 0.77
CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection. Proc Natl Acad Sci U S A (2016) 0.77
Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated gamma delta T-cell-depleted mice. Immunology (1995) 0.76
Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation. J Immunol (2017) 0.75
Increase of Thy-1 antigen on the thymocytes accompanied with their augmented adhesion capacity to thymic epithelial cells in the mice infected with Listeria monocytogenes. Immunology (1993) 0.75
Decreased expression of T-cell costimulatory molecule CD28 on CD4 and CD8 T cells of mexican patients with pulmonary tuberculosis. Tuberc Res Treat (2010) 0.75
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog (2017) 0.75
Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods (1977) 8.43
Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol (1973) 7.68
The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol (1970) 3.94
Quantitative studies of the adoptive immunological memory in mice. I. An age-dependent barrier to syngeneic transplantation. J Exp Med (1966) 3.70
Transfer of adoptive immunity to tuberculosis in mice. Infect Immun (1975) 2.97
Cell-mediated resistance to aerogenic infection of the lung. Am Rev Respir Dis (1971) 2.48
Contact sensitivity in the mouse. IV. The role of lymphocytes and macrophages in passive transfer and the mechanism of their interaction. J Exp Med (1970) 2.23
Passive transfer of resistance to tuberculosis through use of monocytes. Proc Soc Exp Biol Med (1960) 2.22
Induction and expression of immunity after BCG immunization. Infect Immun (1977) 2.06
The immunology of tuberculosis. Am Rev Respir Dis (1982) 1.75
Non-H-2 restriction of expression of passively transferred delayed sensitivity. J Exp Med (1982) 1.27
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01
Mechanisms of acquired resistance in mouse typhoid. J Exp Med (1966) 9.20
The route of enteric infection in normal mice. J Exp Med (1974) 7.99
The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol (1987) 6.12
Host-parasite relations in mouse typhoid. J Exp Med (1966) 5.73
Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol (1968) 5.71
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med (1997) 5.48
Vaccines and cell-mediated immunity. Bacteriol Rev (1974) 5.42
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med (1996) 5.38
Infection-immunity in experimental salmonellosis. J Exp Med (1966) 4.45
Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol (1984) 4.00
The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol (1970) 3.94
Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis (1997) 3.55
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology (1995) 3.45
Experimental Yersinia enterocolitica infection in mice: kinetics of growth. Infect Immun (1974) 3.34
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun (1998) 3.14
Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge. Tuber Lung Dis (1999) 2.81
Comparative immunogenicity of heat-killed and living oral Salmonella vaccines. Infect Immun (1972) 2.72
Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun (2000) 2.63
The effect of cultural conditions on the distribution of Mycobacterium tuberculosis in the spleens and lungs of specific pathogen-free mice. Am Rev Respir Dis (1974) 2.53
Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun (1994) 2.52
Salmonellosis in orally infected specific pathogen-free C57B1 mice. Infect Immun (1972) 2.50
An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol (1997) 2.46
Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1996) 2.43
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun (1992) 2.33
Effect of specific immune mouse serum on the growth of Salmonella enteritidis in nonvaccinated mice challenged by various routes. J Bacteriol (1969) 2.29
Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun (1994) 2.26
Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology (1995) 2.19
Recovery of delayed-type hypersensitivity in mice following suppressive doses of X-radiation. J Immunol (1968) 2.12
Recall of immunity in mice vaccinated with Salmonella enteritidis or Salmonella typhimurium. J Bacteriol (1968) 2.09
Mechanisms in antimicrobial immunity. J Reticuloendothel Soc (1971) 2.08
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect Immun (1995) 2.08
Effect of specific immune mouse serum on the growth of Salmonella enteritidis in mice preimmunized with living or ethyl alcohol-killed vaccines. J Bacteriol (1969) 2.03
Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun (1995) 1.99
Immune response to persistent mycobacterial infection in mice. Infect Immun (1978) 1.96
Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun (1999) 1.95
Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun (2000) 1.92
Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect Immun (1983) 1.90
Suppressor T-cells in BCG-infected mice. Infect Immun (1979) 1.88
Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. Infect Immun (2000) 1.87
Cross-protection against Salmonella enteritidis infection in mice. J Bacteriol (1968) 1.86
Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun (2001) 1.84
Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun (2000) 1.83
Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG montreal. Clin Exp Immunol (1984) 1.82
Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect Immun (2001) 1.80
Heat-labile antigens of Salmonella enteritidis. II. Mouse-protection studies. J Bacteriol (1966) 1.79
Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun (2001) 1.77
Mycobactericidal activity of glutaraldehyde solutions. J Clin Microbiol (1976) 1.77
Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber Lung Dis (1997) 1.76
T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol (2000) 1.76
The immunology of tuberculosis. Am Rev Respir Dis (1982) 1.75
The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli. Cell Immunol (1970) 1.75
Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol (1992) 1.73
The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun (1997) 1.73
Resistance of various strains of mycobacteria to killing by activated macrophages in vivo. J Immunol (1983) 1.72
Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates. Infect Immun (1997) 1.70
Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun (1986) 1.68
Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology (1993) 1.67
Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species. Infect Immun (1971) 1.65
Cellular antimicrobial immunity. CRC Crit Rev Microbiol (1978) 1.62
Growth of a drug-resistant strain of Mycobacterium bovis (BCG) in normal and immunized mice. J Infect Dis (1969) 1.62
Boosting vaccine for tuberculosis. Infect Immun (2001) 1.61
Development of suppressor T cells in mice heavily infected with mycobacteria. Immunology (1980) 1.60
Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle (1985) 1.60
Growth of salmonellae in orally infected germfree mice. Infect Immun (1978) 1.58
Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol (1996) 1.57
Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis. Antimicrob Agents Chemother (1996) 1.57
Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice. Infect Immun (1974) 1.55
Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice. Infect Immun (1975) 1.53
Mycobacterium avium-complex infections and development of the acquired immunodeficiency syndrome: casual opportunist or causal cofactor? Int J Lepr Other Mycobact Dis (1986) 1.53
Polyarthritis associated with Salmonella infection in rats. Infect Immun (1973) 1.52
Role of mononuclear phagocytes in expression of resistance and susceptibility to Mycobacterium avium infections in mice. Infect Immun (1986) 1.49
A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis. Am Rev Respir Dis (1968) 1.48
Listeria monocytogenes infection in beta 2 microglobulin-deficient mice. Infect Immun (1993) 1.48
Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosis. Tuber Lung Dis (1999) 1.48
Relative susceptibility of acid-fast and non-acid-fast bacteria to ultraviolet light. Appl Microbiol (1971) 1.46
Effect of adjuvant on immunogenicity of a heat-killed salmonella vaccine. J Infect Dis (1972) 1.45
Metronidazole therapy in mice infected with tuberculosis. Antimicrob Agents Chemother (1999) 1.45
The specificity of suppressor T cells induced by chronic Mycobacterium avium infection in mice. Clin Exp Immunol (1981) 1.42
Growth of typhoid and paratyphoid bacilli in intravenously infected mice. Infect Immun (1974) 1.42
Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice. J Leukoc Biol (1992) 1.42
Immunological basis for reactivation of tuberculosis in mice. Infect Immun (2001) 1.42
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun (1997) 1.41
The restorative effect of peritoneal macrophages on delayed hypersensitivity following ionizing radiation. Cell Immunol (1971) 1.41
CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol (2001) 1.40
Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun (1994) 1.40
Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice. Antimicrob Agents Chemother (1990) 1.38
Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Infect Immun (1984) 1.36
Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immun (1995) 1.36
Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect Immun (1992) 1.36
Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode. Infect Immun (2000) 1.36
Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes. J Exp Med (1986) 1.36
A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Biol (2000) 1.35